Canaan Partners X LLC
CIK 1673228 · last filed 2020-01-23
Canaan Partners X LLC is a corporate insider who has filed 6 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for ITRM, was dated Jan 23, 2020. Across all open-market trades the lifetime net is +$1.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $379.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$379.65M
3
6
$1.30M
Holdings By Company
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-23 | Iterum Therapeutics plc (ITRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-28 | IDYA | Mixed | +5,321,426 | $8.00M | EDGAR |
| 2018-05-21 | PTGX | Sell (S) | −77,936 | -$474.7K | EDGAR |
| 2018-05-16 | PTGX | Sell (S) | −329,494 | -$2.12M | EDGAR |
| 2018-03-26 | PTGX | Sell (S) | −119,900 | -$2.48M | EDGAR |
| 2018-03-22 | PTGX | Sell (S) | −79,036 | -$1.63M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.